Clinical aspects of idiopathic pulmonary fibrosis

E-poster session
Chairs: M. Veltkamp (De Meern, Netherlands), J. Morisset (Montréal (QC), Canada)

Clusters of comorbidities in idiopathic pulmonary fibrosis T. Prior (Aarhus, Denmark), N. Hoyer (Copenhagen, Denmark), O. Hilberg (Vejle, Denmark), S. Shaker (Copenhagen, Denmark), J. Davidsen (Odense, Denmark), F. Rasmussen (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark)
TORVAN VERSUS GAP: WHICH PERFORMS BETTER? F. Simone (Foggia, Italy), M. L. Bocchino (Napoli , Italy), L. Capitelli (Napoli , Italy), K. Del Vecchio (Foggia, Italy), A. Laricchiuta (Foggia, Italy), G. Scioscia (Foggia, Italy), M. P. Foschino Barbaro (Foggia, Italy), D. Lacedonia (Foggia, Italy)
2-Year survival of patients with IPF with or without GERD: a study using VA national database F. Tang (Miami, United States of America), C. Ramos (Miami, United States of America), M. Mirsaeidi (Miami, United States of America), R. Jackson (Miami, United States of America)
Unraveling unclassifiable interstitial lung disease – a multicenter approach S. Torrisi (Heidelberg, Germany), C. Hyldgaard (Silkeborg, Denmark), S. Kronborg-White (Aarhus, Denmark), C. Ganter (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark)
Diagnosis and treatment of new idiopathic interstitial pneumonias cases: Analysis using the Japanese Registry. T. Ogura (Yokohama, Japan), R. Okuda (Yokohama, Japan), Y. Kondoh (Seto, Japan), H. Taniguchi (Seto, Japan), T. Johkoh (Amagasaki, Japan), J. Fukuoka (Nagasaki, Japan), A. Miyamoto (Tokyo, Japan), R. Egashira (Saga, Japan), A. Hebisawa (Asahi, Japan), F. Sakai (Hidaka, Japan), T. Takemura (Yokohama, Japan), K. Tomii (Kobe, Japan), K. Fujimoto (Kurume, Japan), T. Tanaka (Sayama, Japan), T. Arai (Sakai, Japan), H. Sumikawa (Sakai, Japan), T. Kasai (Sakai, Japan), Y. Nakamura (Hamamatsu, Japan), T. Iwasawa (Yokohama, Japan), Y. Terasaki (Tokyo, Japan), T. Suda (Hamamatsu, Japan), T. Fujisawa (Hamamatsu, Japan), N. Ishikawa (Hiroshima, Japan), N. Arai (Kana, Japan), T. Takihara (Isehara, Japan), M. Hamaguchi (Izumo, Japan), M. Toyoshima (Hamamatsu, Japan), M. Abe (Chiba, Japan), M. Kato (Tokyo, Japan), H. Miyata (Tokyo, Japan), N. Ichihara (Tokyo, Japan), S. Morita (Kyoto, Japan), N. Inase (Hiratsuka, Japan), H. Tomioka (Kobe, Japan), M. Bandoh (Shimotsuke, Japan), K. Kobayashi (Hidaka, Japan), T. Nukiwa (Sendai, Japan)
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre F. Thompson (Southampton, United Kingdom), T. Wallis (Southampton, United Kingdom), K. Pontoppidan (Southampton, United Kingdom), C. Brereton (Southampton, United Kingdom), E. Reid (Southampton, United Kingdom), B. Welham (Southampton, United Kingdom), M. Jones (Southampton, United Kingdom), S. Fletcher (Southampton, United Kingdom)
Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features V. Sholomova (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), A. Yanakaeva (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) A. Romero Ortiz (Granada, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), S. Armengol (Barcelona, Spain), A. Ramon (Barcelona, Spain), M. Morros (Barcelona, Spain)
Idiopathic Pulmonary Fibrosis behavior in the aged population- is it different? O. Hakrush (Haifa, Israel), S. Schneer (Haifa, Israel), Y. Adir (Haifa, Israel)
Gender differences in idiopathic pulmonary fibrosis: are men and women equal or not? L. Sese (Bobigny, France), H. Nunes (Bobigny, France), V. Cottin (Lyon, France), D. Israel-Biet (Paris, France), B. Crestani (Paris, France), S. Guillot Dudoret (Rennes, France), J. Cadranel (Paris, France), B. Wallaert (Lille, France), A. Tazi (Paris, France), B. Maître (Créteil, France), G. Prévot (Toulouse, France), S. Marchand-Adam (Tours, France), S. Hirschi (Strasbourg, France), S. Dury (Reims, France), V. Giraud (Boulogne, France), A. Gondouin (Besançon, France), P. Bonniaud (Dijon, France), J. Traclet (Lyon, France), K. Juvin (Paris, France), R. Borie (Paris, France), Z. Carton (Bobigny, France), J. Caliez (Bobigny, France), O. Freynet (Bobigny, France), T. Gille (Bobigny, France), C. Planes (Bobigny, France), D. Valeyre (Bobigny, France), Y. Uzunhan (Bobigny, France)
PRESERVED FORCED VITAL CAPACITY IS NOT ALWAYS REPRESENTING EARLY IPF G. Bermudo Peloche (Barcelona, Spain), G. Suárez-Cuartin (Barcelona, Spain), P. Rivera Ortega (Barcelona, Spain), J. Rodriguez-Portal (Sevilla, Spain), J. Sauleda (Palma de Mallorca, Spain), B. Nuñez (Palma de Mallorca, Spain), D. Castillo (Barcelona, Spain), M. Aburto (Bizkaia, Spain), K. Portillo (Barcelona, Spain), E. Balcells (Barcelona, Spain), C. Valenzuela (Madrid, Spain), E. Fernandez-Fabrellas (Valencia, Spain), M. González-Budiño (Oviedo, Spain), E. Cano-Jiménez (Lugo, Spain), O. Acosta Fernández (Santa Cruz de Tenerife, Spain), V. Leiro (Vigo, Spain), A. Romero (Granada, Spain), L. Planas-Cerezales (Barcelona, Spain), A. Villar (Barcelona, Spain), A. Moreno (Barcelona, Spain), R. Laporta (Madrid, Spain), V. Vicens-Zygmunt (Barcelona, Spain), M. Molina-Molina (Barcelona, Spain)
Anxiety and depression in ILD and IPF patients. Is there a difference? G. Kounti (Thessaloniki, Greece), K. Markopoulou (Thessaloniki, Greece), C. Tsantiridis (Thessaloniki, Greece), E. Tsapakidou (Thessaloniki, Greece), C. Karachristos (Thessaloniki, Greece), G. Babalis (Thessaloniki, Greece), A. Chloros (Thessaloniki, Greece)
The burden of Idiopathic Pulmonary Fibrosis (IPF): a multimodal study of prevalence, healthcare utilization and survival W. Chia (Kirkcaldy, United Kingdom), F. Harrison (Kirkcaldy, United Kingdom), T. Hartley (Kirkcaldy, United Kingdom), D. Szapiro (Kirkcaldy, United Kingdom), D. Dhasmana (Kirkcaldy, United Kingdom)
Idiopathic pulmonary fibrosis (IPF): the patient journey V. Cottin (Lyon, France), F. Bonella (Essen, Germany), M. Small (Bollington, United Kingdom), J. Siddall (Bollington, United Kingdom), J. Langley (Mechelen, Belgium), Y. Inoue (Osaka, Japan), L. Lancaster (Nashville, TN, United States of America)
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE V. Peláez-Hernández (Mexico City, Mexico), L. Martínez Bautista (Mexico City, Mexico), K. Santillán Reyes (Mexico City, Mexico), G. Luna Rodríguez (Mexico City, Mexico), K. Rosales Castillo (Mexico City, Mexico), A. Orea Tejeda (Mexico City, Mexico), M. Gómez Martínez (Mexico City, Mexico), N. Martínez Luna (Mexico City, Mexico)
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception F. Bonella (Essen, Germany), Y. Inoue (Osaka, Japan), M. Small (Bollington, United Kingdom), J. Siddall (Bollington, United Kingdom), J. Langley (Mechelen, Belgium), V. Cottin (Lyon, France), L. Lancaster (Nashville, TN, United States of America)
Responsiveness and minimal clinically important difference of K-BILD and SGRQ-I T. Prior (Aarhus, Denmark), N. Hoyer (Copenhagen, Denmark), O. Hilberg (Vejle, Denmark), S. Shaker (Copenhagen, Denmark), J. Davidsen (Odense, Denmark), E. Bendstrup (Aarhus, Denmark)
Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare use Y. Inoue (Osaka, Japan), V. Cottin (Lyon, France), M. Small (Bollington, United Kingdom), J. Siddall (Bollington, United Kingdom), J. Langley (Mechelen, Belgium), F. Bonella (Essen, Germany), L. Lancaster (Nashville, TN, United States of America)